Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2019-08-16

Original market date: See footnote 1

1998-07-27

Product name:

AMPICILLIN FOR INJECTION, USP

DIN:

02226995 Electronic product monograph is not available

Company: 

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada  M9W 0C8

Class: 

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

08:12.16.08   AMINOPENICILLINS

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01CA01  AMPICILLIN

Active ingredient group (AIG) number:See footnote 5

0105872005

List of active ingredient(s)
Active ingredient(s) Strength
AMPICILLIN (AMPICILLIN SODIUM) 2 G / VIAL

Application information

Related information

Contact us

Version 3.8.0
Date modified: